Tatsuo Oyake

Iwate Medical University

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Collaborators (5)

Haruki Ujiie

Iwate Medical University

Naoyuki Nishiya

Akinao Okamoto

Fujita Health University

Yutaka Shimazu

Kyoto University Hospital

Ritsuro Suzuki

Shimane University Hospital

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tatsuo Oyake

Research Interests

Explore related searches

Contact this professor

Articles (10)

Collaborators (5)

Haruki Ujiie

Naoyuki Nishiya

Akinao Okamoto

Yutaka Shimazu

Ritsuro Suzuki

Make your next move.

Tatsuo Oyake

Research Interests

Explore related searches

Contact this professor

Articles (10)

Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry

Association of CD8 + T cells expressing nivolumab-free PD-1 with clinical status in a patient with relapsed refractory classical Hodgkin lymphoma.

Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL.

Fungal biomarker monitoring and CT scans for early detection of invasive fungal disease in neutropenic hematological patients

Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study.

Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine

Switching from Intravenous to Oral Tacrolimus Reduces its Blood Concentration in Paediatric Cancer Patients

Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study.

Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation.

[Treatment of secondary engraftment failure with granulocyte colony-stimulating factor and eltrombopag after allogeneic peripheral blood stem cell transplantation in adult T-cell leukemia/lymphoma].

Collaborators (5)

Haruki Ujiie

Naoyuki Nishiya

Akinao Okamoto

Yutaka Shimazu

Ritsuro Suzuki

Make your next move.